Cargando…

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center

INTRODUCTION: Medullary thyroid carcinoma (MTC) is a rare cancer that accounts for 5% of thyroid cancers. Serum calcitonin is a good biomarker for MTC, which is used for diagnosis, prognosis, and monitoring of recurrence. Calcitonin-negative MTC (CNMTC) is rare but confounds diagnostic and prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sun Jung, Yun, Hyeok Jun, Shin, Su-Jin, Lee, Yong Sang, Chang, Hang-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602843/ https://www.ncbi.nlm.nih.gov/pubmed/34803914 http://dx.doi.org/10.3389/fendo.2021.747704

Ejemplares similares

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022)

Serum calcitonin negative Medullary thyroid carcinoma
por: Sand, Michael, et al.
Publicado: (2006)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2021)

Primary thyroid lymphoma: A single-center experience
por: Lee, Jin Seok, et al.
Publicado: (2023)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
por: Jiao, Zan, et al.
Publicado: (2022)

Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance
por: Rafaey, Wania, et al.
Publicado: (2022)

The Difficulty of Post-Operative Surveillance of Calcitonin Negative Medullary Thyroid Cancer
por: Skutnik, Emily, et al.
Publicado: (2021)

Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?
por: Daumerie, Chantal, et al.
Publicado: (2013)

Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017)

Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2020)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
por: Gambardella, Claudio, et al.
Publicado: (2019)

ODP466 Case of Sporadic Medullary Thyroid Cancer Detected by Serum Calcitonin Measurement
por: Juneau, Andrea Kate, et al.
Publicado: (2022)

A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy
por: Licata, Lorena, et al.
Publicado: (2022)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes
por: Fan, Yi, et al.
Publicado: (2022)

Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules
por: Samardzic, Vladimir S., et al.
Publicado: (2023)

Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers
por: Cirello, Valentina, et al.
Publicado: (2021)

Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review
por: Gambardella, Claudio, et al.
Publicado: (2019)

Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma
por: Ukrani, Janta, et al.
Publicado: (2023)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer
por: Andrade, Fernanda, et al.
Publicado: (2019)

Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology
por: Jassal, Karishma, et al.
Publicado: (2022)

The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes
por: Sekiguchi, Toshio
Publicado: (2018)

Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature
por: Contarino, Andrea, et al.
Publicado: (2022)

Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020)

Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
por: Chen, Li, et al.
Publicado: (2020)

IGF-I Influences Everolimus Activity in Medullary Thyroid Carcinoma
por: Gentilin, Erica, et al.
Publicado: (2015)

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
por: Matrone, Antonio, et al.
Publicado: (2022)

Postoperative Neck Ultrasonography Surveillance After Thyroidectomy in Patients With Medullary Thyroid Carcinoma: A Multicenter Study
por: Ahn, Hye Shin, et al.
Publicado: (2018)

The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels
por: Araz, Mine, et al.
Publicado: (2023)

Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence?
por: Huguet, I, et al.
Publicado: (2013)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
por: Batista, Rafael Loch, et al.
Publicado: (2013)

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
por: Fugazzola, L., et al.
Publicado: (2020)

Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma
por: Zhou, Tian-Han, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
por: Zhang, Daqi, et al.
Publicado: (2022)

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
por: Fanciulli, Giuseppe, et al.
Publicado: (2023)

The dilemma of routine testing for calcitonin thyroid nodule’s patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time
por: Trimboli, Pierpaolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c78co1a6ciau44nhs04k7k0bbq